Table 1 Baseline characteristics.
Written advice (n = 37) | BCPP (n = 86) | MDPP (n = 87) | |
|---|---|---|---|
Study centre n (%) | |||
MFT | 32 (87%) | 75 (88%) | 79 (91%) |
T&GICFT | 3 (8%) | 9 (10%) | 7 (8%) |
UHS | 2 (5%) | 2 (2%) | 1 (1%) |
Age median (IQR) | 49 (44–52) | 48 (44–52) | 48 (43–51) |
Pre/postmenopausal n (%) | 24/13 (65/35%) | 55/31 (64/36%) | 51/36 (58/42%) |
Ethnicity n (%) | |||
White | 34 (92%) | 82 (95%) | 84 (96%) |
Asian/Black | 3 (8%) | 4 (5%) | 3 (4%) |
BMI (kg/m2) median (IQR) | 30.4 (28.3–32.8) | 31.1 (28.4–36.1) | 31.6 (27.8–36.2) |
Overweight (BMI 25–29.99 kg/m2) n (%) | 17 (46%) | 37 (42%) | 38 (44%) |
Obese (BMI > 30 kg/m2) n (%) | 20 (54%) | 49 (58%) | 49 (56%) |
Smoking status n (%) | |||
Current | 3 (8%) | 4 (5%) | 5 (6%) |
Previous | 13 (35%) | 29 (33%) | 30 (34%) |
Never | 21 (57%) | 53 (62%) | 52 (60%) |
Years since joining the FHRPC median (IQR) | 5.5 (2.9–10.3) | 4.1 (1.0–10.8) | 5.7 (2.3–12.4) |
Estimated % lifetime BC risk at baseline (T-C) mean (SD) | 26 (9) | 25 (10) | 24 (12) |
Moderate (≥17–29.99%) | 26 (70%) | 66 (77%) | 68 (78%) |
High (>30%) | 11 (30%) | 20 (23%) | 19 (22%) |
Change in breast cancer risk category between joining the FHRPC and the study | |||
Increase | 4 (11%) | 7 (8%) | 7 (8%) |
Stable | 26 (70%) | 43 (50%) | 46 (53%) |
Decrease | 7 (19%) | 30 (34%) | 28 (32%) |
Not updated | 0 (0%) | 7 (8%) | 5 (6%) |
Gene variant status | |||
Positive individual | 1 (3%) | 0 (0%) | 3 (3%) |
Positive family & individual untested | 0 (0%) | 1 (1%) | 3 (3%) |
Positive family & individual negative | 0 (0%) | 3 (3%) | 2 (2%) |
Prescribed BC risk reducing medication | |||
Already taking at baseline | 1 (3%) | 5 (6%) | 3 (3%) |
Commenced at baseline | 4 (11%) | 10 (11%) | 2 (2%) |
Family history of CVDa | 9 (24%) | 22 (26%) | 17 (20%) |
Family history of T2Db | 10 (27%) | 18 (17%) | 31 (36%) |
IMD Quintile | |||
1 (most deprived | 6 (16%) | 13 (15%) | 20 (23%) |
2 | 8 (21%) | 12 (4%) | 12 (14%) |
3 | 8 (22%) | 16 (18%) | 23 (26%) |
4 | 8 (22% | 17 (20%) | 15 (17%) |
5 (least deprived) | 7 (9%) | 28 (33%) | 17(20%) |
Anxiety (PHQ) median (IQR) | 3 (2–7) | 3 (1–5) | 3.5 (1–6.8) |
Moderate/severe n (%) | 3 (9%) | 5 (6%) | 10 (12%) |
Missing | N = 1 | N = 3 | N = 3 |
Depression (GAD) (n = 202) | |||
Median (IQR) | 4 (3–10) | 3 (1.5–6) | 4 (2–7) |
Moderate/severe n (%) | 8 (23%) | 13 (15%) | 10 (12%) |
Binge eating score 4 | 4 (11%) | 8 (10%) | 13 (17%) |
Missing | N = 1 | N = 3 | N = 3 |
Living situation n (%) | |||
Lives with partner | 31 (84%) | 67 (78%) | 69 (79%) |
Lives alone | 3 (8%) | 14 (16%) | 17 (20%) |
Lives in shared house | 3 (8%) | 5 (6%) | 1 (1%) |
Dependent children at home | 25 (69%) | 60 (73%) | 59 (69%) |
Highest education level n (%) | |||
Primary & secondary | 4 (11%) | 15 (17%) | 18 (21%) |
Further | 16 (43%) | 22 (26%) | 19 (22%) |
Higher | 16 (43%) | 46 (57%) | 47 (54%) |
Missing | 1 (3%) | 3 (4%) | 3 (3%) |
Employment status n (%) | |||
Full time | 22 (60%) | 61 (71%) | 60 (69%) |
Part time | 7 (20%) | 19 (22%) | 23 (27%) |
Unemployed/long term sick | 4(10%) | 2 (2%) | 0 (0%) |
Full time student | 2 (5%) | 2 (2%) | 0 (0%) |
Home carer | 0 (0%) | 2 (2%) | 2 (2%) |
Retired | 2 (5%) | 0 (0%) | 2 (2%) |
Any chronic health condition | 29 (78%) | 58 (68%) | 60 (69%) |
Anxiety/depression | 5 (14%) | 9 (10%) | 8 (9%) |
Musculoskeletal | 9 (24%) | 15 (17%) | 17 (20%) |
Asthma | 2 (5%) | 12 (14%) | 5 (6%) |
Gastrointestinal | 2 (5%) | 10 (12%) | 8 (9%) |
Thyroid | 2 (5%) | 5 (6%) | 4 (5%) |
Number of previous weight loss attempts | |||
n (IQR) | 3 (2–6) | 4 (2–9) | 4 (3–10) |
≤2 | 12 (33%) | 25 (29%) | 20 (21%) |
3–4 | 9 (24%) | 21 (24%) | 30 (35%) |
5–9 | 4 (11%) | 20 (23%) | 14 (21%) |
>9 | 12(33%) | 21 (24%) | 17 (20%) |
Previously advised to lose weight by HCP | 16 (43%) | 42 (49%) | 45 (52%) |
Previous NHS weight loss programme | 1 (3%) | 9 (11%) | 6 (7%) |
Previous commercial weight loss programme | 24 (65%) | 61 (71%) | 65 (75%) |
